M. Karoui, A. Rullier, C. Mariette, E. Maillard, A. Bardier, et al.. Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicentre randomised controlled trial (PRODIGE 22).
the 42nd ESMO Congress (ESMO 2017), Sep 2017, Madrid, Spain. pp.476O,
⟨10.1093/annonc/mdx393.003⟩.
⟨hal-01632311⟩